Jump to content
RemedySpot.com

NYC conference - agenda

Rate this topic


Guest guest

Recommended Posts

I have found this event - intended for oncologists - to be the best venue

for keeping up with clinical practice, controversies, and research in

lymphoma.

The CLL Session is on Friday (below)

registration: http://www.lymphomaandmyeloma.com/2011/registration.html

=====

Saturday, October 22, 2011

Welcome and audience survey

Morton , MD

LYMPHOMA SESSION

8:05 am: Introduction to Lymphoma Session

P. Leonard, MD

Session X: Lymphoma biology

Moderator: Rita Shaknovich, MD

8:10 am: New molecular targets in large cell lymphoma

M. Rimsza, MD

8:25 am: BCL-6: a regulator of lymphomagenesis

Ari Melnick, MD

8:40 am: Panel discussion and questions

==

Session XI: Hodgkin’s disease

Moderator: Elstrom, MD

8:50 am: Limited treatment for limited disease?

Volker Diehl, MD

9:10 am: Emerging new agents in Hodgkin’s and lymphoma

Friedberg, MD

9:30 am: Is there a role for consolidation radiation in limited and advanced

Hodgkin’s disease in the era of PET scan?

, MD

9:50 am: Panel discussion and questions

===

Session XII: Special lectures in Lymphoma

Moderator: Morton , MD

10:25 am: Presentation of best lymphoma abstract

10:35 am: The SASS Foundation for Medical Research Award Ceremony

Francis P. Arena, MD - President & Director of Research for the SASS

Foundation

Presentation: Ultmann Award for Contributions to Lymphoma Research

Presenters: Morton , MD and P. Leonard, MD

Recipient: Bertrand Coiffier, MD

10:40 am: Is R-CHOP-21 still the standard for all patients or is there a

role for CHOP-14, ABVCP, EPOCH, etc?

Bertrand Coiffier, MD

11:00 am: The Bruce Waterfall Memorial Lecture in Waldenstrom’s

Macroglobulinemia

Presenter: Morton , Md

Moderator: , MD

Treatment approaches for untreated and relapsed disease

M. Ansell, MD, PhD

11:25 am: Panel discussion and questions

===

Session XIII: Follicular lymphoma

Moderator: Leonard, MD

1:40 pm: Pre-debate audience survey

Debate: Should everyone receive maintenance rituximab?

Yes: Maloney, MD, PhD

No: Bruce E. Cheson, MD

Post-debate audience survey

2:20 pm: Pre-debate audience survey

Debate: Is “watch and wait” passé in asymptomatic follicular lymphoma?

Yes: P. Leonard, MD

No: Myron Czuczman, MD

Post-debate audience survey

3:00 pm: Panel discussion and questions

===

Session XIV: Aggressive lymphoma

Moderator: , MD

3:15 pm: Pre-session audience survey

3:25 pm: Relapsed aggressive lymphoma: what approaches are applicable for

transplant eligible and ineligible patients? What has the CORAL study taught

us?

Craig Moskowitz, MD

3:45 pm: Mantle cell lymphoma: How best to approach and treatment: Is there

a role for maintenance?

Brad Kahl, MD

4:05 pm: Double hit aggressive lymphoma

Kieron Dunleavy, MD

4:25 pm: Pre-session audience survey

4:35 pm: Panel discussion and questions

====

CLL SESSION - Friday

1:10 pm: Introduction to CLL Session

Furman, MD

Session VIII: Treatment approaches I

Moderator: Furman, MD

1:15 pm: Pre-session audience survey

1:25 pm: Introduction to The Prince Family Lecture

1:30 pm: The Prince Family lecture: Is a cure on the horizon?

J. Keating, MD

1:55 pm: Molecular pathogenesis and therapy of CLL

J. Kipps, MD, PhD

2:15 pm: Transplantation in CLL: How major a role?

Edwin Alyea, MD

2:35 pm: Post-session audience survey

2:45 pm: Panel discussion and questions

==Session IX: Treatment approaches II

Moderator: Kanti Rai, MD

3:20 pm: Pre-session audience survey

3:30 pm: Treatment of the elderly: How gentle should it be?

Neil E. Kay, MD

3:50 pm: Non-chemotherapeutic approaches: Can we avoid alkylators and purine

analogues?

O’Brien, MD

4:10 pm: Novel approaches to CLL: Exciting new agents

Furman, MD

4:30 pm: Post-session audience survey

4:40 pm: Panel discussion and questions

Patients Against Lymphoma

www.Lymphomation.org

Evidence-based information on lymphoma, independent of health industry

funding

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...